Rabies post-exposure prophylaxis in Germany - What are the challenges?


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
18 03 2021
Historique:
pubmed: 19 3 2021
medline: 10 8 2021
entrez: 18 3 2021
Statut: epublish

Résumé

Rabies post-exposure prophylaxis (R-PEP) including wound treatment, vaccination and application of rabies immunoglobulin (RIG) is essential in preventing rabies mortality. Today, Germany is officially declared free from terrestrial rabies and rabies is only found in bats. However, physicians in A&E Departments are frequently consulted on the need for R-PEP. We retrospectively analysed patients who received R-PEP at the A&E Department of the University Hospital Bonn between 01.01.2013 and 30.06.2019. Demographic data, travel history, clinical and laboratory findings, previous rabies vaccinations and R-PEP vaccination regimen were recorded. During the study period, 90 patients received R-PEP at the University Hospital Bonn, in 10 cases without indication for R-PEP. Altogether, we found deviations from R-PEP guidelines in 51% (n = 41/80). Infiltration of RIG was missed in 12 patients and incorrectly administrated in 24 patients. Furthermore, vaccination scheme was incorrect in 11 patients. Correct wound washing and documentation of tetanus status was missing in 14% and 63% of patients, respectively. Despite rabies elimination in Germany patients frequently seek advice for R-PEP, the majority returning from foreign travel. Our data show that there is a high need for education on indication for R-PEP before and after travel and for implementation of precise R-PEP guidelines in daily clinical practice.

Identifiants

pubmed: 33734061
doi: 10.1017/S0950268821000601
pii: S0950268821000601
pmc: PMC8161409
doi:

Substances chimiques

Immunoglobulins 0
Rabies Vaccines 0
Tetanus Toxoid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e119

Références

J Travel Med. 2014 Jan-Feb;21(1):62-6
pubmed: 24267775
J Travel Med. 2008 Jan-Feb;15(1):25-30
pubmed: 18217866
J Travel Med. 2013 May-Jun;20(3):148-58
pubmed: 23577860
Am J Epidemiol. 2018 Feb 1;187(2):306-315
pubmed: 29020186
Vaccine. 2012 Jan 5;30(2):126-33
pubmed: 22085557
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709
pubmed: 25881058
PLoS Negl Trop Dis. 2018 Nov 13;12(11):e0006951
pubmed: 30422981
Commun Dis Intell Q Rep. 2012 Jun 30;36(2):E186-7
pubmed: 23186218
Bull World Health Organ. 2016 Sep 1;94(9):635-635A
pubmed: 27708465
Sci Transl Med. 2017 Dec 20;9(421):
pubmed: 29263230
MMWR Recomm Rep. 2010 Mar 19;59(RR-2):1-9
pubmed: 20300058
Euro Surveill. 2013 May 02;18(18):20474
pubmed: 23725773
Emerg Infect Dis. 2015 Apr;21(4):569-77
pubmed: 25811076

Auteurs

P Meyerhoff (P)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.

S Manekeller (S)

Department of Surgery, University Hospital Bonn, Bonn, Germany.

N Saleh (N)

Department of Pediatric Medicine, University Hospital Bonn, Bonn, Germany.

C Boesecke (C)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
German Center for Infection Research (DZIF), Bonn-Cologne, Germany.

S Schlabe (S)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
German Center for Infection Research (DZIF), Bonn-Cologne, Germany.

J C Wasmuth (JC)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
German Center for Infection Research (DZIF), Bonn-Cologne, Germany.

K van Bremen (K)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
German Center for Infection Research (DZIF), Bonn-Cologne, Germany.

A M Eis-Hübinger (AM)

German Center for Infection Research (DZIF), Bonn-Cologne, Germany.
Institute of Virology, University of Bonn, Bonn, Germany.

J von Fischer-Treuenfeld (J)

Pharmacy of the University Hospital Bonn, Bonn, Germany.

T Menting (T)

Occupational Health Service, University Hospital Bonn, Bonn, Germany.

J K Rockstroh (JK)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
German Center for Infection Research (DZIF), Bonn-Cologne, Germany.

C Schwarze-Zander (C)

Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
German Center for Infection Research (DZIF), Bonn-Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH